ConductScience.org, home

Paper766720

Postpsychotic depression in schizophrenia.

McGlashan TH and 1 other. Arch Gen Psychiatry, 1976. Cited by 275 papers, by iCite.

Cite this record

ConductScience Library. Postpsychotic depression in schizophrenia. Papers, record 766720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/766720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Postpsychotic depression in schizophrenia.
PubMed
Journal
Arch Gen Psychiatry
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
275
iCite
Relative citation ratio, by iCite
13.4
iCite
Revised in PubMed
2019-07-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McGlashan THT H
2Carpenter WT JrW T

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DepressionMajor topic
SchizophreniaMajor topic
Affect
Diagnosis, Differential
Humans
Prognosis
Psychotherapy
Schizophrenic Psychology
Terminology as Topic
Thinking

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 275 citations.

PMIDTitleJournalYearIn PapersSource
42095058A systematic review investigating the relationship between green and blue spaces and depression in older adults via DNA methylation.Environ Epigenet2026https://conductscience.org/library/papers/42095058PubMed
42041642Post-Psychotic Depression: A Comprehensive Narrative Review.Diseases2026https://conductscience.org/library/papers/42041642PubMed
41233335Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes.Schizophrenia (Heidelb)2025https://conductscience.org/library/papers/41233335PubMed
39006901Diagnosis and treatment depression in schizophrenia.Consort Psychiatr2020https://conductscience.org/library/papers/39006901PubMed
37644044Identifying the mediating role of socioeconomic status on the relationship between schizophrenia and major depressive disorder: a Mendelian randomisation analysis.Schizophrenia (Heidelb)2023https://conductscience.org/library/papers/37644044PubMed
36482878A case of postpsychotic depression improved by switching antipsychotic monotherapy.Neuropsychopharmacol Rep2023https://conductscience.org/library/papers/36482878PubMed
35328011Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity.Genes (Basel)2022https://conductscience.org/library/papers/35328011PubMed
33151310Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials.Int J Neuropsychopharmacol2021https://conductscience.org/library/papers/33151310PubMed
32581869Psychiatric Diagnoses and Treatment Preceding Schizophrenia in Adolescents Aged 9-17 Years.Front Psychiatry2020https://conductscience.org/library/papers/32581869PubMed
32246196A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression.Eur Arch Psychiatry Clin Neurosci2020https://conductscience.org/library/papers/32246196PubMed
31477079Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder.BMC Psychiatry2019https://conductscience.org/library/papers/31477079PubMed
27069064The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.Schizophr Bull2016https://conductscience.org/library/papers/27069064PubMed
26970100The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.Schizophr Bull2016https://conductscience.org/library/papers/26970100PubMed
25834445Augmentation with antidepressants in schizophrenia treatment: benefit or risk.Neuropsychiatr Dis Treat2015https://conductscience.org/library/papers/25834445PubMed
25762938Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Front Psychiatry2015https://conductscience.org/library/papers/25762938PubMed
25171855Testing trait depression as a potential clinical domain in schizophrenia.Schizophr Res2014https://conductscience.org/library/papers/25171855PubMed
25055980The effects of aging on insight into illness in schizophrenia: a review.Int J Geriatr Psychiatry2014https://conductscience.org/library/papers/25055980PubMed
23734941Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem.Psychol Med2014https://conductscience.org/library/papers/23734941PubMed
22661807Schizophrenia - insight, depression: a correlation study.Indian J Psychol Med2012https://conductscience.org/library/papers/22661807PubMed
22058481Post-psychotic depression in schizophrenics: (a prospective study).Indian J Psychiatry1980https://conductscience.org/library/papers/22058481PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/766720

GET https://conductscience.org/api/papers/v1/766720/cited_by?page=2